Literature DB >> 25086066

Dictyostelium LvsB has a regulatory role in endosomal vesicle fusion.

Kristin Falkenstein1, Arturo De Lozanne2.   

Abstract

Defects in human lysosomal-trafficking regulator (Lyst) are associated with the lysosomal disorder Chediak-Higashi syndrome. The absence of Lyst results in the formation of enlarged lysosome-related compartments, but the mechanism for how these compartments arise is not well established. Two opposing models have been proposed to explain Lyst function. The fission model describes Lyst as a positive regulator of fission from lysosomal compartments, whereas the fusion model identifies Lyst as a negative regulator of fusion between lysosomal vesicles. Here, we used assays that can distinguish between defects in vesicle fusion versus fission. We compared the phenotype of Dictyostelium discoideum cells defective in LvsB, the ortholog of Lyst, with that of two known fission defect mutants (μ3- and WASH-null mutants). We found that the temporal localization characteristics of the post-lysosomal marker vacuolin, as well as vesicular acidity and the fusion dynamics of LvsB-null cells are distinct from those of both μ3- and WASH-null fission defect mutants. These distinctions are predicted by the fusion defect model and implicate LvsB as a negative regulator of vesicle fusion.
© 2014. Published by The Company of Biologists Ltd.

Entities:  

Keywords:  Chediak–Higashi syndrome; Endosome fusion; LvsB; Lyst

Mesh:

Substances:

Year:  2014        PMID: 25086066      PMCID: PMC4197084          DOI: 10.1242/jcs.138123

Source DB:  PubMed          Journal:  J Cell Sci        ISSN: 0021-9533            Impact factor:   5.285


  47 in total

1.  Coronin and vacuolin identify consecutive stages of a late, actin-coated endocytic compartment in Dictyostelium.

Authors:  R Rauchenberger; U Hacker; J Murphy; J Niewöhner; M Maniak
Journal:  Curr Biol       Date:  1997-03-01       Impact factor: 10.834

Review 2.  Lysosomal and cytosolic pH as regulators of exocytosis in mouse macrophages.

Authors:  R Sundler
Journal:  Acta Physiol Scand       Date:  1997-12

3.  Identification and mutation analysis of the complete gene for Chediak-Higashi syndrome.

Authors:  D L Nagle; M A Karim; E A Woolf; L Holmgren; P Bork; D J Misumi; S H McGrail; B J Dussault; C M Perou; R E Boissy; G M Duyk; R A Spritz; K J Moore
Journal:  Nat Genet       Date:  1996-11       Impact factor: 38.330

4.  Identification of the homologous beige and Chediak-Higashi syndrome genes.

Authors:  M D Barbosa; Q A Nguyen; V T Tchernev; J A Ashley; J C Detter; S M Blaydes; S J Brandt; D Chotai; C Hodgman; R C Solari; M Lovett; S F Kingsmore
Journal:  Nature       Date:  1996-07-18       Impact factor: 49.962

5.  Targeted gene disruption reveals a role for vacuolin B in the late endocytic pathway and exocytosis.

Authors:  N Jenne; R Rauchenberger; U Hacker; T Kast; M Maniak
Journal:  J Cell Sci       Date:  1998-01       Impact factor: 5.285

6.  Direct vesicular transport of MHC class II molecules from lysosomal structures to the cell surface.

Authors:  R Wubbolts; M Fernandez-Borja; L Oomen; D Verwoerd; H Janssen; J Calafat; A Tulp; S Dusseljee; J Neefjes
Journal:  J Cell Biol       Date:  1996-11       Impact factor: 10.539

7.  A post-lysosomal compartment in Dictyostelium discoideum.

Authors:  H Padh; J Ha; M Lavasa; T L Steck
Journal:  J Biol Chem       Date:  1993-03-25       Impact factor: 5.157

8.  The Beige/Chediak-Higashi syndrome gene encodes a widely expressed cytosolic protein.

Authors:  C M Perou; J D Leslie; W Green; L Li; D M Ward; J Kaplan
Journal:  J Biol Chem       Date:  1997-11-21       Impact factor: 5.157

9.  Examination of the endosomal and lysosomal pathways in Dictyostelium discoideum myosin I mutants.

Authors:  L A Temesvari; J M Bush; M D Peterson; K D Novak; M A Titus; J A Cardelli
Journal:  J Cell Sci       Date:  1996-03       Impact factor: 5.285

10.  The giant organelles in beige and Chediak-Higashi fibroblasts are derived from late endosomes and mature lysosomes.

Authors:  J K Burkhardt; F A Wiebel; S Hester; Y Argon
Journal:  J Exp Med       Date:  1993-12-01       Impact factor: 14.307

View more
  6 in total

Review 1.  The road to lysosome-related organelles: Insights from Hermansky-Pudlak syndrome and other rare diseases.

Authors:  Shanna L Bowman; Jing Bi-Karchin; Linh Le; Michael S Marks
Journal:  Traffic       Date:  2019-06       Impact factor: 6.215

2.  Differences in Granule Morphology yet Equally Impaired Exocytosis among Cytotoxic T Cells and NK Cells from Chediak-Higashi Syndrome Patients.

Authors:  Samuel C C Chiang; Stephanie M Wood; Bianca Tesi; Himmet Haluk Akar; Waleed Al-Herz; Sandra Ammann; Fatma Burcu Belen; Umran Caliskan; Zühre Kaya; Kai Lehmberg; Turkan Patiroglu; Huseyin Tokgoz; Ayşegül Ünüvar; Wendy J Introne; Jan-Inge Henter; Magnus Nordenskjöld; Hans-Gustaf Ljunggren; Marie Meeths; Stephan Ehl; Konrad Krzewski; Yenan T Bryceson
Journal:  Front Immunol       Date:  2017-04-18       Impact factor: 7.561

Review 3.  Lysosomal size matters.

Authors:  Mariana E G de Araujo; Gudrun Liebscher; Michael W Hess; Lukas A Huber
Journal:  Traffic       Date:  2019-12-06       Impact factor: 6.215

4.  Deficiency in Lyst function leads to accumulation of secreted proteases and reduced retinal adhesion.

Authors:  Xiaojie Ji; Lihong Zhao; Ankita Umapathy; Bernard Fitzmaurice; Jieping Wang; David S Williams; Bo Chang; Jürgen K Naggert; Patsy M Nishina
Journal:  PLoS One       Date:  2022-03-03       Impact factor: 3.752

5.  An actin cytoskeletal barrier inhibits lytic granule release from natural killer cells in patients with Chediak-Higashi syndrome.

Authors:  Aleksandra Gil-Krzewska; Mezida B Saeed; Anna Oszmiana; Elizabeth R Fischer; Kathryn Lagrue; William A Gahl; Wendy J Introne; John E Coligan; Daniel M Davis; Konrad Krzewski
Journal:  J Allergy Clin Immunol       Date:  2017-12-11       Impact factor: 10.793

6.  Selective Ablation of Megalin in the Retinal Pigment Epithelium Results in Megaophthalmos, Macromelanosome Formation and Severe Retina Degeneration.

Authors:  Tina Storm; Thomas Burgoyne; Joshua L Dunaief; Erik I Christensen; Clare Futter; Rikke Nielsen
Journal:  Invest Ophthalmol Vis Sci       Date:  2019-01-02       Impact factor: 4.799

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.